Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury

Kristian P. Doyle, Katherine L. Suchland, Thomas M P Ciesielski, Nikola S. Lessov, David Grandy, Thomas (Tom) Scanlan, Mary Stenzel-Poore

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE - Mild hypothermia confers profound neuroprotection in ischemia. We recently discovered 2 natural derivatives of thyroxine, 3-iodothyronamine (T1AM) and thyronamine (T0AM), that when administered to rodents lower body temperature for several hours without induction of a compensatory homeostatic response. We tested whether T1AM- and T0AM-induced hypothermia protects against brain injury from experimental stroke. METHODS - We tested T1AM and T0AM 1 hour after and 2 days before stroke in a mouse model of focal ischemia. To determine whether T1AM and T0AM require hypothermia to protect against stroke injury, the induction of hypothermia was prevented. RESULTS - T1AM and T0AM administration reduced body temperature from 37°C to 31°C. Mice given T1AM or T0AM after the ischemic period had significantly smaller infarcts compared with controls. Mice preconditioned with T1AM before ischemia displayed significantly smaller infarcts compared with controls. Pre- and postischemia treatments required the induction of hypothermia. T1AM and T0AM treatment in vitro failed to confer neuroprotection against ischemia. CONCLUSIONS - T1AM and T0AM, are potent neuroprotectants in acute stroke and T1AM can be used as antecedent treatment to induce neuroprotection against subsequent ischemia. Hypothermia induced by T1AM and T0AM may underlie neuroprotection. T1AM and T0AM offer promise as treatments for brain injury.

Original languageEnglish (US)
Pages (from-to)2569-2576
Number of pages8
JournalStroke
Volume38
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Hypothermia
Thyroxine
Ischemia
Stroke
Wounds and Injuries
Induced Hypothermia
Body Temperature
Brain Injuries
Neuroprotective Agents
Therapeutics
Rodentia
Neuroprotection
thyronamine
3-iodothyronamine

Keywords

  • Hypothermia
  • Neuroprotection
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. / Doyle, Kristian P.; Suchland, Katherine L.; Ciesielski, Thomas M P; Lessov, Nikola S.; Grandy, David; Scanlan, Thomas (Tom); Stenzel-Poore, Mary.

In: Stroke, Vol. 38, No. 9, 09.2007, p. 2569-2576.

Research output: Contribution to journalArticle

Doyle, Kristian P. ; Suchland, Katherine L. ; Ciesielski, Thomas M P ; Lessov, Nikola S. ; Grandy, David ; Scanlan, Thomas (Tom) ; Stenzel-Poore, Mary. / Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. In: Stroke. 2007 ; Vol. 38, No. 9. pp. 2569-2576.
@article{bcea26c080cd4f7db33b2025fe856ca7,
title = "Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury",
abstract = "BACKGROUND AND PURPOSE - Mild hypothermia confers profound neuroprotection in ischemia. We recently discovered 2 natural derivatives of thyroxine, 3-iodothyronamine (T1AM) and thyronamine (T0AM), that when administered to rodents lower body temperature for several hours without induction of a compensatory homeostatic response. We tested whether T1AM- and T0AM-induced hypothermia protects against brain injury from experimental stroke. METHODS - We tested T1AM and T0AM 1 hour after and 2 days before stroke in a mouse model of focal ischemia. To determine whether T1AM and T0AM require hypothermia to protect against stroke injury, the induction of hypothermia was prevented. RESULTS - T1AM and T0AM administration reduced body temperature from 37°C to 31°C. Mice given T1AM or T0AM after the ischemic period had significantly smaller infarcts compared with controls. Mice preconditioned with T1AM before ischemia displayed significantly smaller infarcts compared with controls. Pre- and postischemia treatments required the induction of hypothermia. T1AM and T0AM treatment in vitro failed to confer neuroprotection against ischemia. CONCLUSIONS - T1AM and T0AM, are potent neuroprotectants in acute stroke and T1AM can be used as antecedent treatment to induce neuroprotection against subsequent ischemia. Hypothermia induced by T1AM and T0AM may underlie neuroprotection. T1AM and T0AM offer promise as treatments for brain injury.",
keywords = "Hypothermia, Neuroprotection, Stroke",
author = "Doyle, {Kristian P.} and Suchland, {Katherine L.} and Ciesielski, {Thomas M P} and Lessov, {Nikola S.} and David Grandy and Scanlan, {Thomas (Tom)} and Mary Stenzel-Poore",
year = "2007",
month = "9",
doi = "10.1161/STROKEAHA.106.480277",
language = "English (US)",
volume = "38",
pages = "2569--2576",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury

AU - Doyle, Kristian P.

AU - Suchland, Katherine L.

AU - Ciesielski, Thomas M P

AU - Lessov, Nikola S.

AU - Grandy, David

AU - Scanlan, Thomas (Tom)

AU - Stenzel-Poore, Mary

PY - 2007/9

Y1 - 2007/9

N2 - BACKGROUND AND PURPOSE - Mild hypothermia confers profound neuroprotection in ischemia. We recently discovered 2 natural derivatives of thyroxine, 3-iodothyronamine (T1AM) and thyronamine (T0AM), that when administered to rodents lower body temperature for several hours without induction of a compensatory homeostatic response. We tested whether T1AM- and T0AM-induced hypothermia protects against brain injury from experimental stroke. METHODS - We tested T1AM and T0AM 1 hour after and 2 days before stroke in a mouse model of focal ischemia. To determine whether T1AM and T0AM require hypothermia to protect against stroke injury, the induction of hypothermia was prevented. RESULTS - T1AM and T0AM administration reduced body temperature from 37°C to 31°C. Mice given T1AM or T0AM after the ischemic period had significantly smaller infarcts compared with controls. Mice preconditioned with T1AM before ischemia displayed significantly smaller infarcts compared with controls. Pre- and postischemia treatments required the induction of hypothermia. T1AM and T0AM treatment in vitro failed to confer neuroprotection against ischemia. CONCLUSIONS - T1AM and T0AM, are potent neuroprotectants in acute stroke and T1AM can be used as antecedent treatment to induce neuroprotection against subsequent ischemia. Hypothermia induced by T1AM and T0AM may underlie neuroprotection. T1AM and T0AM offer promise as treatments for brain injury.

AB - BACKGROUND AND PURPOSE - Mild hypothermia confers profound neuroprotection in ischemia. We recently discovered 2 natural derivatives of thyroxine, 3-iodothyronamine (T1AM) and thyronamine (T0AM), that when administered to rodents lower body temperature for several hours without induction of a compensatory homeostatic response. We tested whether T1AM- and T0AM-induced hypothermia protects against brain injury from experimental stroke. METHODS - We tested T1AM and T0AM 1 hour after and 2 days before stroke in a mouse model of focal ischemia. To determine whether T1AM and T0AM require hypothermia to protect against stroke injury, the induction of hypothermia was prevented. RESULTS - T1AM and T0AM administration reduced body temperature from 37°C to 31°C. Mice given T1AM or T0AM after the ischemic period had significantly smaller infarcts compared with controls. Mice preconditioned with T1AM before ischemia displayed significantly smaller infarcts compared with controls. Pre- and postischemia treatments required the induction of hypothermia. T1AM and T0AM treatment in vitro failed to confer neuroprotection against ischemia. CONCLUSIONS - T1AM and T0AM, are potent neuroprotectants in acute stroke and T1AM can be used as antecedent treatment to induce neuroprotection against subsequent ischemia. Hypothermia induced by T1AM and T0AM may underlie neuroprotection. T1AM and T0AM offer promise as treatments for brain injury.

KW - Hypothermia

KW - Neuroprotection

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=34548267177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548267177&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.106.480277

DO - 10.1161/STROKEAHA.106.480277

M3 - Article

C2 - 17690312

AN - SCOPUS:34548267177

VL - 38

SP - 2569

EP - 2576

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -